TotalMarketCap

Mannkind

MNKDNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.214 B

$3.78 -3.94%

Close of 6 Nov 2026

As of 6 Nov 2026, Mannkind (MNKD) has a market capitalization of $1.21B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$349.0M

#2055 by revenue

Earnings

$5.86M

#2147 by earnings

Shares outstanding

321,640,118

Latest filing cover page

P/E ratio

207.0

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #136Lb PharmaceuticalsLBRX$1.23B
  2. #137Silence TherapeuticsSLN$1.23B
  3. #138MannkindMNKD$1.21B
  4. #139Avalyn PharmaAVLN$1.18B
  5. #140Amphastar PharmaceuticalsAMPH$1.18B

What if Mannkind were worth as much as…

Open the what-if tool →

Gold $28.2T

$87,816.38

Per share 23,263× higher

Bitcoin $1.53T

$4,751.59

Per share 1,259× higher

Apple $5.02T

$15,599.03

Per share 4,132× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Mannkind are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.